Xtant Medical Holdings Inc (XTNT)
0.7252
+0.03
(+4.74%)
USD |
NYAM |
May 17, 16:00
0.7252
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Research and Development Expense (TTM): 1.689M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.689M |
December 31, 2023 | 1.336M |
September 30, 2023 | 1.076M |
June 30, 2023 | 0.815M |
March 31, 2023 | 0.876M |
December 31, 2022 | 0.915M |
September 30, 2022 | 0.834M |
June 30, 2022 | 0.867M |
March 31, 2022 | 0.869M |
December 31, 2021 | 0.87M |
September 30, 2021 | 0.847M |
June 30, 2021 | 0.761M |
March 31, 2021 | 0.629M |
December 31, 2020 | 0.66M |
September 30, 2020 | 0.789M |
June 30, 2020 | 0.816M |
March 31, 2020 | 0.915M |
December 31, 2019 | 0.932M |
September 30, 2019 | 1.198M |
June 30, 2019 | 1.342M |
March 31, 2019 | 1.55M |
Date | Value |
---|---|
December 31, 2018 | 1.702M |
September 30, 2018 | 1.777M |
June 30, 2018 | 1.934M |
March 31, 2018 | 2.156M |
December 31, 2017 | 2.441M |
September 30, 2017 | 2.641M |
June 30, 2017 | 3.066M |
March 31, 2017 | 3.21M |
December 31, 2016 | 3.411M |
September 30, 2016 | 3.640M |
June 30, 2016 | 3.505M |
March 31, 2016 | 3.012M |
December 31, 2015 | 2.546M |
September 30, 2015 | 2.007M |
June 30, 2015 | 1.591M |
March 31, 2015 | 1.622M |
December 31, 2014 | 1.443M |
September 30, 2014 | 1.303M |
June 30, 2014 | 0.9622M |
March 31, 2014 | 0.8097M |
December 31, 2013 | 0.8402M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.629M
Minimum
Mar 2021
1.689M
Maximum
Mar 2024
0.9518M
Average
0.8695M
Median
Research and Development Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 24.91M |
Retractable Technologies Inc | 0.5812M |
InfuSystems Holdings Inc | -- |
Asensus Surgical Inc | 34.98M |
Catheter Precision Inc | 0.272M |